Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1380089-33-7 | MDL No. : | MFCD24387374 |
Formula : | C7H8BrNO3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | USGKSLUGKUUZSM-UHFFFAOYSA-N |
M.W : | 234.05 | Pubchem ID : | 67814794 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 5 |
Fraction Csp3 : | 0.43 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 45.03 |
TPSA : | 52.33 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.89 cm/s |
Log Po/w (iLOGP) : | 2.34 |
Log Po/w (XLOGP3) : | 1.18 |
Log Po/w (WLOGP) : | 1.66 |
Log Po/w (MLOGP) : | 0.83 |
Log Po/w (SILICOS-IT) : | 2.1 |
Consensus Log Po/w : | 1.62 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.14 |
Solubility : | 1.68 mg/ml ; 0.00716 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.87 |
Solubility : | 3.12 mg/ml ; 0.0133 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.97 |
Solubility : | 0.253 mg/ml ; 0.00108 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.5 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | Stage #1: With N-Bromosuccinimide In acetic acid at 110℃; for 1 h; Stage #2: With sodium hydrogencarbonate In acetic acid at 20℃; |
[00237] (4-Bromo-3-methylisoxazol-5-yl)methyl acetate. . To a solution of (3- methylisoxazol-5-yl)methyl acetate (0.979 g, 6.31 mmol) in AcOH (10 mL, 175 mmol) was added N-bromosuccinimide (1.30 g, 7.30 mmol) and H2SO4 (0.65 mL, 12.19 mmol). The reaction was heated to 110 °C. After 1 h, the reaction mixture was cooled to roomtemperature and carefully poured into a beaker containing ice and saturated NaHC03. The bi- phasic was vigorously stirred and basic solution (pH -8-9) was extracted with EtOAc (2 x 15 mL). The organic layer was washed with 2percent sodium thiosulfate, washed with brine (20 mL), dried over Na2S04, and concentrated to give a light yellow oil. The oil was purified on Biotage system (isocratic elution 10percent EtOAc : 90percent Hexanes) to give the titled compound (1.30 g, 5.55 mmol, 88percent Yield) as a colorless yellow oil. LC/MS m/z 234 [M+H]+. |
88% | at 110℃; for 1 h; | To a solution of (3-methylisoxazol-5-yl)methyl acetate (0.979 g, 6.31 mmol) in AcOH (10 mL, 175 mmol) was added N-bromosuccinimide (1.30 g, 7.30 mmol) and H2SO4 (0.65 mL, 12.19 mmol). The reaction was heated to 110 °C. After 1 h, the reaction mixture was cooled to room temperature and carefully poured into a beaker containing ice and saturated NaHCO3. The bi-phasic mixture was vigorously stirred and basic solution (pH 8-9) was extracted with EtOAc (2 x 15 mL). The organic layer was washed with 2percent sodium thiosulfate, washed with brine (20 mL), dried over Na2SO4, and concentrated to give a light yellow oil. The oil was purified on Biotage system (isocratic elution 10percent EtOAc : 90percent Hexanes) to give the titled compound (1.30 g, 5.55 mmol, 88percent Yield) as a colorless yellow oil. LC/MS m/z 234 [M+H]+. |
74.8% | at 110℃; for 1 h; | To a solution of (3-methylisoxazol-5-yl)methyl acetate (200 g, 1.29 mol) in AcOH (2.00 L) was added N-bromosuccinimide (230 g, 1.29 mol) and H2S04 (140 mL, 2.62 mol). The reaction was heated to 110 °C. After 1 h, the reaction mixture was cooled to room temperature and carefully poured into a beaker containing ice and saturated NaHCO3. The biphasic mixture was vigorously stirred and basic solution (pH —8-9) was extracted with EtOAc (2x). The organic layer was washed with 2percent sodium thiosulfate, washed with brine 0 dried over Na2SO4, and concentrated to give a light yellow oil. The oil was purified on Biotage system (isocratic elution 10percent EtOAc : 90percent Hexanes) to give the titled compound (225 g, 74.8percent yield) as a colorless yellow oil. LC/MS m/z 234 [M+H]+ |
31% | at 110℃; for 1 h; | To a solution of compound 12 ( 130 mg, 837.9 umol, 1 eq) in acetic acid (1.5 mL) was added NBS (178.9 mg, 1 mmoi, 1.2 eq) and sulfuric acid (164 mg, 1.7 mmoi, 2 eq). The reaction mixture was heated at 110 °C for 1 h when TLC showed the starting material was consumed completely. The reaction mixture was cooled to 25 °C and carefully poured into a vigorously stirred solution of ice cooled saturated NaHC03. The solution (pH 8-9) was extracted with EtOAc (3 x 20 mL). The combined organic fractions were washed with 2percent sodium thiosuifate (50 mL), brine(2 x 50 mL), dried over anhydrous Na2S04, filtered and concentrated under vacuum. The residue was purified by column chromatography (0-10percent EtOAc in PE) to afford compound 13 (60 mg, 256.4 umol, 31percent yield) as a yellow oil: H-l NM R (400 MHz, CDCI3) δ 2.14 (s, 3H), 2.32 (s, 3H), 5.17 (s, 2H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
83% | at 120℃; for 3 h; | To a solution of 20 (3.20 g, 28.32 mmol) in AcOH (5 mE) was addedN-bromosuccinimide (6.05 g, 33.98 mmol) and H2S04 (0.1 mE). The reaction mixture was heated to 120° C. for 3 h. The reaction mixture was concentrated, the residue was dissolved in EtOAc (200 mE), washed with saturated NaHCO3 (100 mE), saturated Na25203 (3x50 mE) and brine (100 mE). The organic layer was dried over sodium sulfate, filtered and concentrated to give 21(5.50 g, 83percent) as a pale yellow solid: ‘H NMR (300 MHz, CDC13) ö 5.16 (s, 2H), 2.31 (s, 3H), 2.13 (s, 3H). |
83% | at 120℃; for 3 h; | General procedure: To a solution 20 (3.20g, 28.32mmol) in AcOH (5mL) was added N-bromosuccinimide(6.05g, 33.98mmol) and H2SO4 (0.1mL). The reaction mixture was heated to120 continued 3h. The reaction mixture was concentrated,The residue was dissolved in EtOAc (200mL) at, washed with saturatedNaHCO3 (100mL), saturated Na2S2O3 (3 × 50mL) and brine(100 mL) and washed. The organic layer was dried over sodium sulfate,filtered and concentrated to give a pale yellow solid of 21 (5.50g,83percent) |
[ 850832-54-1 ]
Methyl 4-bromo-5-methylisoxazole-3-carboxylate
Similarity: 0.74
[ 377053-86-6 ]
Methyl 3-(4-bromophenyl)isoxazole-5-carboxylate
Similarity: 0.66
[ 517870-15-4 ]
Methyl 5-(4-bromophenyl)isoxazole-3-carboxylate
Similarity: 0.60
[ 850832-54-1 ]
Methyl 4-bromo-5-methylisoxazole-3-carboxylate
Similarity: 0.74
[ 63366-79-0 ]
Ethyl 3-methylisoxazole-5-carboxylate
Similarity: 0.71
[ 1004-96-2 ]
Methyl 3-methylisoxazole-5-carboxylate
Similarity: 0.68
[ 123770-62-7 ]
Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate
Similarity: 0.66
[ 377053-86-6 ]
Methyl 3-(4-bromophenyl)isoxazole-5-carboxylate
Similarity: 0.66
[ 850832-54-1 ]
Methyl 4-bromo-5-methylisoxazole-3-carboxylate
Similarity: 0.74
[ 63366-79-0 ]
Ethyl 3-methylisoxazole-5-carboxylate
Similarity: 0.71
[ 123770-62-7 ]
Ethyl 5-(hydroxymethyl)isoxazole-3-carboxylate
Similarity: 0.66